Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 121, Issue 1, 2005, Pages 104-109

  Arora, Raksha ^a   Kumar, Arunaz ^a   Prusty, Bhupesh K ^b   Kailash, Uma ^b   Batra, Swaraj ^a   Das, Bhudev C ^b,c  

^a LOK NAYAK HOSPITAL   (India)

^b MAULANA AZAD MEDICAL COLLEGE   (India)

^c NONE

Author keywords

Cervical cancer; Human papillomavirus (HPV); Inflammation; Pap smear; Polymerase chain reaction (PCR); Squamous intraepithelial lesions (SIL)

Indexed keywords

PRIMER DNA;

ADULT; ARTICLE; CELL DAMAGE; COLPOSCOPY; CYTODIAGNOSIS; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; INFECTION RISK; NORMAL HUMAN; ONCOVIRINAE; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; UTERINE CERVICITIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX EPITHELIUM; VIRUS DETECTION; VIRUS INFECTION;

EID: 21244475882     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.11.025     Document Type: Article

References (59)

1. H. zur Hausen Papillomaviruses and cancer: from basic studies to clinical application Nature Rev Cancer 2 2002 350 392
2. WHO Bull. Control of cancer of the cervix, a WHO meeting. Bull WHO 1986;64:607-18.
3. Luthra UK, Pandey RN, Prabhakar AK, Ravi R. Proceedings of the second Asian conference on cancer, Singapore, 1975.
4. B.C. Das, A. Sehgal, N.S. Murthy, and V. Gopalkrishna Human papillomavirus and cervical cancer in Indian women The Lancet 2 8674 1989 1271
5. J.D. Buckley, R.W.C. Harris, R. Doll, M.P. Vessey, and P.T. Williams Case control study of the husbands of women with dysplasia or carcinoma of the cervix uteri The Lancet 2 8254 1981 1010 1015
6. R.W.C. Harris, L.A. Brinton, and R.H. Cowdell Characteristics of women with dysplasia or carcinoma in-situ of the cervix uteri Br J Cancer 42 3 1980 359 369
7. W.C. Reeves, L.A. Brinton, M.M. Brenes, and E. Quiroz Case control study of cervical cancer in Herrara Province, Republic of Panama Int J Cancer 36 1985 55
8. M.V. Zunzunegui, M.C. King, G.F. Coria, and J. Charles Male influences of cervical cancer risk Am J Epidemiol 123 1986 302 307
9. E.G. Jones, I. Mac Donald, and L. Breslow A study of epidemiologic factors in carcinoma of the uterine cervix Am J Obstet Gynaecol 76 1958 1 10
10. A. Hildsheim, P. Gravitt, M.H. Schiffman, and R.J. Kurman Determinants of genital human papillomavirus infection in low-income women in Washington DC Sex Transm Dis 20 5 1993 279 285
11. W. Winkelstein Jr. Smoking and cervical cancer: hypothesis Am J Epidemiol 106 1977 257 259
12. W. Winkelstein Jr. Smoking and cervical cancer - current status: a review Am J Epidemiol 131 6 1990 945 957
13. J.G. Boyce, T. Lu, J.H. Nelson, and R.G. Freuchter Oral contraceptives and cervical carcinoma Am J Obstet Gynaecol 128 1977 761 766
14. V. Gopalkrishna, N.S. Murthy, J.K. Sharma, and M. Roy Increased human papillomavirus infection with increasing number of pregnancies in Indian women J Infect Dis 171 1995 254 255
15. W.C. Reeves, L.A. Brinton, M. Garcia, and M.M. Brenes Human papillomavirus infection and cervical cancer in Latin America N Engl J Med 320 22 1989 1437 1441
16. F.X. Bosch, N. Munoz, S.D. Sanjose, and I. Izarzugaza Risk factors for cervical cancer in Columbia and Spain Int J Cancer 52 1992 750 758
17. Eluf-Neto, M. Booth, N. Munoz, and F.X. Bosch Human papillomavirus and invasive cervical cancer in Brazil Br J Cancer 69 1994 114 119
18. M.T. Kouri, S. Morsberger, A. Carrillo, and A. Mohar HPV prevalence among Mexican women with neoplastic and normal cervices Gynaecol Oncol 70 1998 115 120
19. S. Chinchareon, R. Herrero, N. Munoz, and F.X. Bosch Risk factors for cervical cancer in Thailand: a case control study J Natl Cancer Inst 90 1 1998 50 57
20. F.X. Bosch, N. Munoz, and S.D. Sanjose Human papillomavirus and the other risk factors for cervical cancer Biomed Pharmacother 51 1997 268 275
21. K. Gjooen, A.O. Oslen, P. Magnus, B. Grinde, T. Sauer, and I. Orstavik Prevalence of human papillomavirus in cervical scrapes as analyzed by PCR, in a population based sample of women with and without cervical dysplasia APMIS 104 1 1996 68 74
22. S. Siritantikorn, S. Laiweijpithaya, and U. Siripanyaphinyo Detection and typing of human papillomavirus DNAs in normal cervix, intra-epithelial neoplasia and cervical cancer in Bangkok Southeast Asian J Trop Med Public Health 28 4 1997 707 710
23. N. Munoz, R. Herraro, E. Lazcano, and H. Posso HPV prevalence survey in the general populations Abstract book of the fourth international multidisciplinary congress Eurogin 2000, Paris 2000
24. T.B. Lawley, R.B. Lee, and R. Kapela The significance of moderate and severe inflammation on Class I Papanicolaou smear Obstet Gynaecol 76 6 1990 997 999
25. R.M. DeMay Cytopathology of false negatives preceding cervical carcinomas Am J Obstet Gynecol 175 1996 1110 1113
26. K. Nanda, D.C. McCrory, and E.R. Myers Accuracy of the Papanicolaou test in the screening for and follow-up of cervical cytologic abnormalities: a systematic review Ann Intern Med 132 2000 810 819
27. M.T. Fahey, L. Irwig, and P. Macaskill Meta-analysis of Pap test accuracy Am J Epidemiol 141 1995 680 689
28. R. Arora, K. Vijaya, S. Habeebulah, and A. Oumachighui Colposcopic evaluation of unhealthy cervix J Obstet Gynaecol Ind 50 6 2000 102 103
29. P.E. Castle, S. Wacholder, and M.E. Sherman Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women Cancer 95 10 2002 2145 2151
30. G. Hudelist, M. Manavi, and Pischinger Ki Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade Gynecol Oncol 92 3 2004 873 880
31. K.S. Cuschieri, H.A. Cubie, and M.W. Whitley Multiple high-risk HPV infections are common in cervical neoplasia and young women in a cervical screening population J Clin Pathol 57 1 2004 68 72
32. N.W. Bulkmans, L. Rozendaal, and P.J. Snijders POBSCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44102 women Int J Cancer 110 1 2004 94 101
33. H. zur Hausen Human papillomavirus and their possible role in squamous cell carcinoma Curr Top Microbiol Immunol 78 1979 1 30
34. J. Cuzick, G. Terry, L. Ho, T. Holligworth, and M. Anderson Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia Br J Cancer 69 1 1994 167 171
35. V. Gopalkrishna, A. Francis, J.K. Sharma, and B.C. Das A simple and rapid method of high quality DNA isolation from cervical scrapes in detection of human papillomavirus infection J Virol Methods 36 1 1992 63 72
36. R.K. Saiki, D.H. Gelfand, S. Stoffel, and S.J. Scharf Primer-directed amplification of DNA with a thermostable DNA Polymerase Science 239 4839 1988 487 491
37. B.C. Das, J.K. Sharma, V. Gopalkrishna, and D.K. Das A high frequency of human papillomavirus DNA sequences in cervical carcinoma of Indian women as revealed by Southern Blot Hybridisation and Polymerase Chain Reaction J Med Virol 36 1992 239 245
38. E. Paraskevaidis, E.J. Davidson, and V. Malamou-Mitsi An observational study of women with positive HPV-DNA tests and normal cytology and colposcopy Eur J Gynecol Oncol 23 4 2002 320 322
39. J. Callaghan, S. Karim, S. Mortlock, M. Wintert, and N. Woodward Hybrid capture as means of detecting human papillomavirus DNA from liquid-based cytology specimens: a preliminary evaluation Br J Biomed Sci 58 3 2001 184 189
40. M.F.D. Baay, E. Smits, and W.A.A. Tjalma Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women Int J Cancer 108 2004 258 261
41. P.W. Melkert, E. Hopman, and A.J. van den Brule Prevalence of HPV in cytomorphologically normal cervical smear, as determined by the polymerase chain reaction, is age dependent Int J Cancer 53 1993 919 923
42. J. Cuzick, A. Szarewski, J. Terry, and L. Ho Human papillomavirus testing in primary cervical screening Lancet 345 1995 1533 1536
43. R.D. Burk, P. Kelly, and J. Feldman Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors Sex Transm Dis 23 1996 333 341
44. A.M. De Roda Husman, J.M. Walboomers, and E. Hopman HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: the age-related pattern J Med Virol 46 1995 97 192
45. E.A. Morrison, G.Y. Ho, and S.H. Vermund Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study Int J Cancer 49 1991 6 13
46. J. Cuzick, E. Beverley, and L. Ho HPV testing in primary screening of older women Br J Cancer 81 1999 554 558
47. E. Fasal, M.E. Simmons, and J.B. Kampert Factors associated with high and low risk of cervical neoplasia J Natl Cancer Inst 66 4 1981 631 636
48. M. Terris, F. Wilson, and J.H. Nelson Jr. Comparative epidemiology of invasive carcinoma of cervix, carcinoma in situ and cervical dysplasia Am J Epidemiol 112 2 1980 253 257
49. T. Rohan, V. Mann, J. McLaughlin, and D.G. Harnish PCR detected genital human papillomavirus infection: prevalence and association with risk factors for cervical cancer Int J Cancer 49 6 1991 856 860
50. C. Ley, H.M. Bauer, and Reingold Determinants of genital human papillomavirus infection in young women J Natl Cancer Inst 83 14 1991 997 1003
51. K.L. Kotloff, S.S. Wasserman, K. Russ, and S. Shapiro Detection of genital Human papillomavirus and associated cytological abnormalities among college women Sex Transm Dis 25 2 1998 243 250
52. A.J. Remmnick, J.M. Walboomers, T.J. Helmerhorst, and F.J. Voorhorst The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months Int J Cancer 61 1995 306 311
53. L. Rozendaal, J.M. Walboomers, and J.C. van der Linden PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears Int J Cancer 68 6 1996 766 769
54. C.B. Woodman, S. Collins, and H. Winter Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study Lancet 357 9271 2001 1831 1836
55. N. Ylitalo, P. Sorensen, and A.M. Josefsson Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study Lancet 134 1 2001 35
56. M.E. Sherman, A.T. Lorincz, and D.R. Scott Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis J Natl Cancer Inst 95 1 2003 46 52
57. Y.L. Oh, K.J. Shin, J. Han, and D.S. Kim Significance of high-risk human papillomavirus detection by polymerase chain reaction in primary cervical cancer screening Cytopathology 12 1 2001 75 83
58. J.T. Cox, A.T. Lorincz, M.H. Schiffman, M.E. Sherman, A. Cullen, and R.J. Kurman Human Papillomavirus by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance Am J Obstet Gynecol 172 3 1995 946 954
59. C.J. Meijer, L. Rozendaal, F.J. Voorhorst, R. Verheijen, T.J. Helmerhorst, and J.M. Walboomers Human papillomavirus and screening for cervical cancer: state of art and prospects Ned Tijdschr Geneeskd 144 35 2000 1675 1679